The N‐terminal copper‐binding domain of the amyloid precursor protein protects against Cu2+neurotoxicity in vivo
- 2 September 2004
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 18 (14) , 1701-1703
- https://doi.org/10.1096/fj.03-1349fje
Abstract
The amyloid precursor protein (APP) contains a Cu binding domain (CuBD) localized between amino acids 135 and 156 (APP135-156), which can reduce Cu 2+ to Cu1+ in vitro. The physiological function of this APP domain has not yet being established; nevertheless several studies support the notion that the CuBD of APP is involved in Cu homeostasis. We used APP synthetic peptides to evaluate their protective properties against Cu2+ neurotoxicity in a bilateral intra-hippocampal injection model. We found that human APP135-156 protects against Cu 2+ -induced neurotoxic effects, such as, impairment of spatial memory, neuronal cell loss, and astrogliosis. APP135-156 lacking two histidine residues showed protection against Cu2+; however, APP135-156 mutated in cysteine 144, a key residue in the reduction of Cu2+ to Cu1+, did not protect against Cu2+ neurotoxicity. In accordance with recent reports, the CuBD of the Caenorhabditis elegans, APL- 1, protected against Cu2+ neurotoxicity in vivo. We also found that Cu2+ neurotoxicity is associated with an increase in nitrotyrosine immunofluorescence as well as with a decrease in Cu2+ uptake. The CuBD of APP therefore may play a role in the detoxification of brain Cu.Keywords
Funding Information
- International Copper Association
This publication has 39 references indexed in Scilit:
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Characterization of Copper Interactions with Alzheimer Amyloid β PeptidesJournal of Neurochemistry, 2000
- Cysteine 144 Is a Key Residue in the Copper Reduction by the β‐Amyloid Precursor ProteinJournal of Neurochemistry, 1999
- The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)Science, 1996
- A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowthJournal of Neuroscience, 1994
- apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor.Proceedings of the National Academy of Sciences, 1993
- Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor proteinNeuron, 1993
- Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor.Proceedings of the National Academy of Sciences, 1992
- Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteasesNeuroscience Letters, 1992
- The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowthNeuron, 1992